Dishman Carbogen swings to Rs57.9 Cr consolidated loss as margins crash to 8.9% YoY

Dishman Carbogen Amcis (consolidated, the primary basis) posted a net loss of Rs57.88 Cr in Q1 FY27, reversing a Rs23.41 Cr profit in Q1 FY26 and a Rs21.74 Cr profit in Q4 FY26 - a turnaround to loss on both a YoY and QoQ basis, with EPS at -Rs3.69 versus +Rs1.49 a year ago. Revenue from operations fell 4.3% YoY to Rs677.64 Cr and 20.4% QoQ from Rs851.40 Cr (Q4 is seasonally the group's strongest quarter). Operating margin (EBITDA/revenue, company-reported) collapsed to 8.87% from 19.87% YoY and 19.14% QoQ, and net margin swung to -8.54% from +3.31% YoY - a sharp compression on both lines. The squeeze sits mainly on employee costs, not the one-off item: employee benefits expense rose to 57.4% of revenue (Rs389.10 Cr) from 49.7% YoY (Rs351.90 Cr) even as revenue declined, the single largest driver of the margin collapse. Net material cost (cost of materials consumed adjusted for inventory changes) also rose to roughly 16.9% of revenue from 13.9% YoY. A Rs1.69 Cr exceptional charge for abandoned QIP transaction costs hit PBT on both standalone and consolidated statements, but pre-exceptional operating profit was already negative Rs49.53 Cr consolidated - adjusting both years for their respective exceptional items still shows a swing from an adjusted profit of roughly Rs26 Cr a year ago to an adjusted loss of roughly Rs56 Cr now, so the one-off is not what drove this into the red. Standalone (the India entity) was weaker still, with a net loss of Rs23.91 Cr versus a Rs2.67 Cr profit YoY on just Rs57.08 Cr of revenue and operating margin of -20.71%, underscoring that India operations remain a small, currently loss-making sliver of a group whose scale sits in the European/Swiss subsidiaries. No specific street consensus for this quarter surfaced in available coverage; broker commentary instead frames a broader FY27 earnings-recovery thesis built on easing input costs and a richer revenue mix, a thesis this print does not support in its first quarter. Against management's own prior guidance - a Q3 FY26 concall target of restoring consolidated EBITDA margin to 25-26% within two years, alongside a French-facility breakeven goal for FY27 - this quarter's 8.87% margin is a clear miss and a step in the wrong direction from that trajectory; the FY26 full-year margin guidance of 19.5-20% itself was roughly met in Q4 FY26 (19.14%) but that guidance window has now closed. Management's own framing in the filing (note 9) attributes the exceptional charge to abandoning a planned QIP equity raise 'due to adverse market conditions and an altered fundraising plan' - consistent with the company instead raising debt this quarter (Rs18 Cr of NCDs placed on June 9) and immediately after quarter-end (board approval for a further Rs75 Cr NCD issuance on August 12); consolidated debt-equity rose to 0.48x from 0.35x YoY, evidence of the pivot from equity to debt funding. This sets up Q2 FY27 as the quarter to watch for whether the employee-cost ratio normalizes and whether management addresses the gap between this print and its 25-26% margin ambition, given the prior concall's confident, 'very optimistic' long-term tone now stands in direct tension with a quarter that swung the group into loss.